Hunigest SR 200 Tablet contains 200 mg of natural micronized progesterone, a bioidentical hormone essential for regulating the menstrual cycle and maintaining pregnancy. This sustained-release formulation ensures a gradual and consistent release of progesterone, optimizing therapeutic efficacy and minimizing fluctuations in hormone levels. Progesterone plays a crucial role in preparing the endometrium for implantation, supporting early pregnancy, and preventing uterine contractions. Hunigest SR 200 is indicated for the treatment of progesterone deficiency, luteal phase support in assisted reproductive technologies, management of menstrual disorders such as amenorrhea or abnormal uterine bleeding, and prevention of preterm birth in high-risk pregnancies. It may also be used in hormone replacement therapy for menopausal symptoms where progesterone supplementation is required. The natural micronized form enhances bioavailability and mimics endogenous progesterone activity. Administration should follow medical guidance, with dosage tailored to individual patient needs. Common side effects may include dizziness, fatigue, headache, and breast tenderness. Contraindications include known hypersensitivity to progesterone, unexplained vaginal bleeding, active thromboembolic disorders, and certain hormone-dependent cancers. Regular monitoring by a healthcare professional is recommended to assess therapeutic response and detect any adverse effects. Hunigest SR 200 Tablet offers an effective option for progesterone supplementation with improved patient compliance due to its sustained-release properties.